Bourne Lent Asset Management Inc Bristol Myers Squibb CO Transaction History
Bourne Lent Asset Management Inc
- $258 Million
- Q2 2025
A detailed history of Bourne Lent Asset Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bourne Lent Asset Management Inc holds 132,641 shares of BMY stock, worth $6.11 Million. This represents 2.38% of its overall portfolio holdings.
Number of Shares
132,641
Previous 135,091
1.81%
Holding current value
$6.11 Million
Previous $8.24 Million
25.49%
% of portfolio
2.38%
Previous 3.54%
Shares
28 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.64BCall Options Held
22.5MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.98 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.31 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.98 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.36 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.26 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $98B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...